Ann-Kathrin Ozga

7PUBLICATIONS
39CO-AUTHORS
Obstetrics and gynaecologyCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedWomen's studies (incl. girls' studies)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 16, 2025
Influence of tamoxifen on ocular morphology and function.

Piotr Strzalkowski, Alicja Strzalkowska, Maximiliane von der Ahe

|Aug 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.

Hans Christoph Diener, Nina Becher, Susanne Sehner

|Apr 09, 2024
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.

Gregory Y H Lip, Julius Nikorowitsch, Susanne Sehner

|Nov 13, 2023
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h.

Nina Becher, Tobias Toennis, Emanuele Bertaglia

|Jan 28, 2023
Gender differences and cooperation in medical authorships - an analysis of the recent ten years in five key medical disciplines.

Jin Yamamura, Isabel Molwitz, Ann-Kathrin Ozga

|Jun 04, 2020
Reevaluation of risk factors for time to subsequent events after first stroke occurrence using a new weighted all-cause effect measure.

Ann-Kathrin Ozga, Bernhard Rauch, Frederick Palm

Pageof 2

Frequent Collaborators

3 joint publications

Andreas Goette

3 joint publications

Alexander Fierenz

3 joint publications

Nina Becher

3 joint publications

Tobias Toennis